RecruitingNot ApplicableNCT06194344

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis: A Randomized Control Pilot Study

Sponsor

The University of Texas Health Science Center, Houston

Enrollment

40 participants

Start Date

Mar 5, 2024

Study Type

INTERVENTIONAL

Conditions

Psychosis

Summary

The purpose of this study is to see how feasible is the use of compact EEG and paired audio technology to administer sleep interventions for inpatients with psychosis, to see if individuals that receive individualized technology-based sleep interventions experience improvements in sleep quality and to see if individuals that receive individualized technology-based sleep interventions experience improvements in symptomatology

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing personalized imagery scripts — guided mental imagery exercises tailored to each person — to see if they improve sleep, reduce psychotic symptoms, and lower suicidal thoughts in people hospitalized with psychosis. **You may be eligible if...** - You are currently hospitalized with a primary diagnosis of a schizophrenia spectrum disorder or a mood disorder with psychotic features - You have been assessed as capable of providing informed consent - You have significant sleep problems (insomnia severity score ≥8) or nightmares at least once a week **You may NOT be eligible if...** - Your psychosis is caused primarily by substance use or a medical condition - You have an intellectual or developmental disability - You have a neurodegenerative condition such as dementia - You have an implanted device such as a pacemaker - You are currently on one-to-one observation for safety reasons Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALIndividualized imagery

Study personnel will assist participants to create scripts that foster relaxation and safety. Objects, places, and/or scenarios that foster participant relaxation, sense of safety, and/or positive emotions will be identified. Participants will write or type the generated scenario using highly detailed elements (e.g., including visual, olfactory, auditory, tactile, and gustatory sensations, as applicable) associated with the imagery. Study personnel will assist with recording the imagery scripts; audio files will be recorded using an audio recording application. The imagery scripts will be played at night via Bluetooth earbuds connected to the Muse app and script recording while laying down to sleep. The imagery rehearsal prompts will play for approximately 15 minutes, based on 10-20-minute recommendations across imagery rehearsal therapy (IRT) studies

BEHAVIORALControl

Participants will wear the earbuds, with use of Muse S headband to collect outcome data without the individualized imagery scripts.

Locations(1)

The University of Texas Health Science Center at Houston

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06194344

Related Trials

Examining the Effects of Estradiol on Neural and Molecular Response to Reward

NCT052822771 location

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

NCT0694794120 locations

Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis

NCT0579640113 locations

Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis

NCT070568942 locations

Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis

NCT070018782 locations